Research Papers

14 of 39 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
No oxidative stress or DNA damage in peripheral blood mononuclear cells after exposure to particles from urban street a…
Hemmingsen JG; Jantzen K; Møller P; Loft S.
Mutagenesis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Formation of DNA adducts in wild-type and transgenic mice expressing human sulfotransferases 1A1 and 1A2 after oral exp…
Høie AH; Monien BH; Sakhi AK; Glatt H; Hjertholm H; Husøy T.
Mutagenesis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Next-generation sequencing technologies: breaking the sound barrier of human genetics.
Bahassi el M; Stambrook PJ.
Mutagenesis (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Human urinary mutagenicity after wood smoke exposure during traditional temazcal use.
Long AS; Lemieux CL; Yousefi P; Ruiz-Mercado I; Lam NL; Orellana CR; White PA; Smith KR; Holland N.
Mutagenesis (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
Automation and validation of micronucleus detection in the 3D EpiDerm™ human reconstructed skin assay and correlation w…
Chapman KE; Thomas AD; Wills JW; Pfuhler S; Doak SH; Jenkins GJ.
Mutagenesis (Unknown)
Published: 2014
2/6 Transparent
Funding Declared
CYP1A1 and Cnr nitroreductase bioactivated niclosamide in vitro.
Beristain-Castillo E; Martínez-Vázquez M; Camacho-Carranza R; Espinosa-Aguirre JJ.
Mutagenesis (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Seven benzimidazole pesticides combined at sub-threshold levels induce micronuclei in vitro.
Ermler S; Scholze M; Kortenkamp A.
Mutagenesis (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR.
Mutagenesis (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs.
Creton S; Aardema MJ; Carmichael PL; Harvey JS; Martin FL; Newbold RF; O'Donovan MR; Pant K; Poth A; Sakai A; Sasaki K; Scott AD; Schechtman LM; Shen RR; Tanaka N; Yasaei H.
Mutagenesis (Unknown)
Published: 2011
2/6 Transparent
Funding Declared
Characterisation of Muta™Mouse λgt10-lacZ transgene: evidence for in vivo rearrangements.
Shwed PS; Crosthwait J; Douglas GR; Seligy VL.
Mutagenesis (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
In vitro evaluation of baseline and induced DNA damage in human sperm exposed to benzo[a]pyrene or its metabolite benzo…
Sipinen V; Laubenthal J; Baumgartner A; Cemeli E; Linschooten JO; Godschalk RW; Van Schooten FJ; Anderson D; Brunborg G.
Mutagenesis (Unknown)
Published: 2010
1/6 Transparent
Funding Declared
Combining the in vivo comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretati…
Vasquez MZ.
Mutagenesis (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
The Xpc gene markedly affects cell survival in mouse bone marrow.
Fischer JL; Kumar MA; Day TW; Hardy TM; Hamilton S; Besch-Williford C; Safa AR; Pollok KE; Smith ML.
Mutagenesis (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
ECVAM retrospective validation of in vitro micronucleus test (MNT).
Corvi R; Albertini S; Hartung T; Hoffmann S; Maurici D; Pfuhler S; van Benthem J; Vanparys P.
Mutagenesis (Unknown)
Published: 2008
2/6 Transparent
Data